Journal of Oral Medicine and Pain

Korean Academy of Orofacial Pain and Oral Medicine (대한안면통증구강내과학회)
권호 표지
DOI QR코드

DOI QR Code

Influence of Hyaluronic Acid on the Different Levels of Lysozyme and Peroxidase in the Aspects of Candidacidal Activities

  • Kim, Jihoon (Department of Oral Medicine and Oral Diagnosis, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Kim, Yoon-Young (Department of Oral Medicine and Oral Diagnosis, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Chang, Ji-Youn (Department of Oral Medicine and Oral Diagnosis, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Kho, Hong-Seop (Department of Oral Medicine and Oral Diagnosis, School of Dentistry and Dental Research Institute, Seoul National University)
  • Received : 2018.02.03
  • Accepted : 2018.03.07
  • Published : 2018.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of the study was to investigate the influences of hyaluronic acid on the candidacidal activities of lysozyme, the peroxidase system, and the glucose oxidase-mediated peroxidase (GO-PO) system at different concentrations of antimicrobial enzymes. Methods: Hyaluronic acid was used at a final concentration of 0.5 mg/mL. Hen egg-white lysozyme (HEWL) was used at concentrations ranging from 10 to $100{\mu}g/mL$. The peroxidase system included bovine lactoperoxidase (bLPO), potassium thiocyanate (KSCN, 1 mM), and hydrogen peroxide ($100{\mu}M$). The GO-PO system included bLPO, KSCN (1 mM), glucose oxidase (10 units/mL), and glucose ($30{\mu}g/mL$). The final concentration of bLPO in the peroxidase and GO-PO systems ranged from 12.5 to $100{\mu}g/mL$. Candida albicans strains ATCC 10231, 11006, and 18804 were utilized. Candidacidal activities of antimicrobials and the influence of hyaluronic acid on their candidacidal activities were determined based on colony forming units. Results: Candidacidal activities of the peroxidase and GO-PO systems increased with increasing concentrations of bLPO. This tendency was the same in the presence or absence of hyaluronic acid. Candidacidal activity of HEWL was not significantly concentration-dependent. Candidacidal activities of the GO-PO system were higher than those of the corresponding peroxidase system. Candidacidal activity was inhibited in the presence of hyaluronic acid in the following order: HEWL, the peroxidase system, and the GO-PO system. Conclusions: Hyaluronic acid inhibited the candidacidal activities of HEWL, the peroxidase system, and the GO-PO system. The GO-PO system exhibited better candidacidal activity than HEWL and the peroxidase system both in the presence and absence of hyaluronic acid.

Keywords

References

  1. Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 2002;8:23-29. https://doi.org/10.1034/j.1601-0825.2002.1o781.x
  2. Almond A. Hyaluronan. Cell Mol Life Sci 2007;64:1591-1596. https://doi.org/10.1007/s00018-007-7032-z
  3. Park MS, Chang JY, Kang JH, Park KP, Kho HS. Rheological properties of hyaluronic acid and its effects on salivary enzymes and candida. Oral Dis 2010;16:382-387. https://doi.org/10.1111/j.1601-0825.2009.01650.x
  4. Lenander-Lumikari M, Loimaranta V. Saliva and dental caries. Adv Dent Res 2000;14:40-47. https://doi.org/10.1177/08959374000140010601
  5. Pogrel MA, Lowe MA, Stern R. Hyaluronan (hyaluronic acid) in human saliva. Arch Oral Biol 1996;41:667-671. https://doi.org/10.1016/S0003-9969(96)00050-7
  6. Pogrel MA, Low MA, Stern R. Hyaluronan (hyaluronic acid) and its regulation in human saliva by hyaluronidase and its inhibitors. J Oral Sci 2003;45:85-91. https://doi.org/10.2334/josnusd.45.85
  7. Lee JY, Kim YY, Chang JY, Park MS, Kho HS. The effects of peroxidase on the enzymatic and candidacidal activities of lysozyme. Arch Oral Biol 2010;55:607-612. https://doi.org/10.1016/j.archoralbio.2010.06.001
  8. Kang JH, Kim YY, Chang JY, Kho HS. Influences of hyaluronic acid on the anticandidal activities of lysozyme and the peroxidase system. Oral Dis 2011;17:577-583. https://doi.org/10.1111/j.1601-0825.2011.01807.x
  9. Cho MA, Kim YY, Chang JY, Kho HS. Interactions between hyaluronic acid, lysozyme, and the glucose oxidase-mediated lactoperoxidase system in enzymatic and candidacidal activities. Arch Oral Biol 2013;58:1349-1356. https://doi.org/10.1016/j.archoralbio.2013.06.015
  10. Van Damme MP, Moss JM, Murphy WH, Preston BN. Binding of hyaluronan to lysozyme at various pHs and salt concentrations. Biochem Int 1991;24:605-613.
  11. Van Damme MP, Moss JM, Murphy WH, Preston BN. Binding properties of glycosaminoglycans to lysozyme--effect of salt and molecular weight. Arch Biochem Biophys 1994;310:16-24. https://doi.org/10.1006/abbi.1994.1134
  12. Moss JM, Van Damme MP, Murphy WH, Preston BN. Dependence of salt concentration on glycosaminoglycan-lysozyme interactions in cartilage. Arch Biochem Biophys 1997;348:49-55. https://doi.org/10.1006/abbi.1997.0365
  13. Green SP, Baker MS, Lowther DA. Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex. J Rheumatol 1990;17:1670-1675.
  14. Sakai A, Akifusa S, Itano N, et al. Potential role of high molecular weight hyaluronan in the anti-Candida activity of human oral epithelial cells. Med Mycol 2007;45:73-79. https://doi.org/10.1080/13693780601039607
  15. Marquis G, Montplaisir S, Garzon S, Strykowski H, Auger P. Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans . Lab Invest 1982;46:627-636.
  16. Tobgi RS, Samaranayake LP, MacFarlane TW. In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 1988;3:35-39. https://doi.org/10.1111/j.1399-302X.1988.tb00603.x
  17. Lenander-Lumikari M. Inhibition of Candida albicans by the Peroxidase/SCN-/$H_2O_2$ system. Oral Microbiol Immunol 1992;7:315-320. https://doi.org/10.1111/j.1399-302X.1992.tb00595.x
  18. Kho HS, Kim YY, Chang JY, Kim MJ, Lee SG. Candidacidal activities of the glucose oxidase-mediated lactoperoxidase system. Arch Oral Biol 2012;57:684-688. https://doi.org/10.1016/j.archoralbio.2011.11.007
  19. Tenovuo JO. Nonimmunoglobulin defense factors in human saliva. In: Tenovuo JO, ed. Human saliva: clinical chemistry and microbiology. Boca Raton: CRC Press; 1989. pp. 55-91.
  20. Korpela A, Yu X, Loimaranta V, et al. Lactoperoxidase inhibits glucosyltransferases from Streptococcus mutans in vitro. Caries Res 2002;36:116-121. https://doi.org/10.1159/000057869
  21. Petit JF, Jolles P. Purification and analysis of human saliva lysozyme. Nature 1963;200:168-169. https://doi.org/10.1038/200168a0
  22. Marquis G, Garzon S, Strykowski H, Auger P. Cell walls of normal and lysozyme-damaged blastoconidia of Candida albicans : localization of surface factor 4 antigen and vicinal-glycol staining. Infect Immun 1991;59:1312-1318.
  23. Wright CD, Bowie JU, Gray GR, Nelson RD. Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Infect Immun 1983;42:76-80.
  24. Jurysta C, Bulur N, Oguzhan B, et al. Salivary glucose concentration and excretion in normal and diabetic subjects. J Biomed Biotechnol 2009;2009:430426.
  25. Soares MS, Batista-Filho MM, Pimentel MJ, Passos IA, Chimenos-Kustner E. Determination of salivary glucose in healthy adults. Med Oral Patol Oral Cir Bucal 2009;14:e510-e513.